21 USC 356 - Annual reporting on drug shortages

Editorial Notes

Amendments

2022—Subsec. (a)(3) to (5). Puspan. L. 117–328, § 3616(span)(1)(A), (B), added pars. (3) and (4) and redesignated former par. (3) as (5). Former pars. (4) and (5) redesignated (6) and (7), respectively.

Subsec. (a)(5)(A). Puspan. L. 117–328, § 3616(span)(1)(C), substituted “paragraph (9)” for “paragraph (7)”.

Subsec. (a)(6) to (9). Puspan. L. 117–328, § 3616(span)(1)(A), redesignated pars. (4) to (7) as (6) to (9), respectively.

2016—Subsec. (a). Puspan. L. 114–255, in introductory provisions, substituted “Not later than March 31 of each calendar year,” for “Not later than the end of calendar year 2013, and not later than the end of each calendar year thereafter,” and inserted “, with respect to the preceding calendar year,” after “a report”.

Statutory Notes and Related Subsidiaries

Effective Date of 2022 Amendment

Puspan. L. 117–328, div. FF, title III, § 3616(span)(2), Dec. 29, 2022, 136 Stat. 5875, provided that:

“The amendments made by paragraph (1) [amending this section] shall apply with respect to reports submitted under section 506C–1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356c–1) on or after March 31, 2024.”